The Nebraska Medical Center
Programs
Program 1 [2018]
ONCOLOGY SERVICE LINE CANCER TREATMENT SERVICES OFFERED BY THE CORPORATION INCLUDE TREATMENT OF LYMPHOMA, LEUKEMIA, MULTIPLE MYELOMA, HEAD AND NECK, BREAST, GASTROINTESTINAL, PANCREATIC, LUNG, GENITOURINARY PROSTATE, GYNECOLOGIC, MELANOMA, BRAIN AND SPINE CANCERS. THE PATIENTS ARE SUPPORTED BY RESEARCH THAT IS CONDUCTED ON THE UNMC CAMPUS. THE CORPORATION IS THE ONLY CLINICAL CANCER CENTER IN ITS SERVICE AREA DESIGNATED BY THE NATIONAL CANCER INSTITUTE. IN ADDITION TO TREATMENT AND CLINICAL TRIALS THE CORPORATION OFFERS SUPPORT GROUPS, SOCIAL WORK, PAIN MANAGEMENT, FINANCIAL COUNSELORS, SUVIVORSHIP GROUPS, GENETIC COUNSELING, AND A VARIETY OF ADDITIONAL PATIENT SUPPORTIVE SERVICES. IN JUNE 2017, THE CORPORATION OPENED THE FRED & PAMELA BUFFETT CANCER CENTER. THE CENTER IS JOINTLY OWNED WITH UNMC AND IS ONE OF THE FOREMOST CANCER RESEARCH AND TREATMENT FACILITIES IN THE COUNTRY. IT IS THE SITE OF INPATIENT HOSPITAL CARE, AS WELL AS OUTPATIENT AND DIAGNOSTIC CARE. UNMC'S FACILITIES, WITHIN THE CENTER, HOUSE RESEARCH LABS. TNMC ALSO OPERATES CANCER TREATMENT LOCATIONS IN BELLEVUE, IN WEST OMAHA AT ITS VILLAGE POINTE LOCATION, AND IN SHENADOAH, IOWA. IN ADDITION, AS ONE OF THE BUSIEST PROGRAMS IN THE WORLD, THE BONE MARROW TRANSPLANTATION PROGRAM SERVED 190 PATIENTS IN THE YEAR ENDED JUNE 30, 2018. A 24/7 EMERGENCY AND EVALUATION TREATMENT CENTER IS DEDICATED TO CANCER AND TRANSPLANT PATIENTS. THE PROGRAM BENEFITS FROM THE RESEARCH CONDUCTED ON THE CORPORATION/UNMC CAMPUS AND THE COOPERATIVE CARE PROGRAM WHICH ASSISTS PATIENTS TO PREPARE FOR AND RECOVER FROM THE TRANSPLANT IN A HOME-LIKE SETTING WITH A CARE PARTNER OF THEIR CHOOSING. THE PROGRAM IS HOUSED IN THE LIED TRANSPLANT CENTER AND RECOGNIZES THE IMPORTANCE OF ENVIRONMENT TO THE PATIENT'S OVERALL WELL-BEING. DURING FISCAL YEAR 2017, THE ONCOLOGY SERVICE LINE TREATED 116,016 CASES AND OVER 26,027 PATIENT DAYS. APPROXIMATELY 41% OF THE NET REVENUE WASDERIVED FROM INPATIENT CASES.GeographiesNot indicatedDatesJul 1, 2017 – Jun 30, 2018Source990No causes providedNo populations provided–$208.8MProgram 2 [2018]
HEART AND VASCULAR SERVICE LINE TNMC PROVIDES A WIDE RANGE OF CARDIOVASCULAR SERVICES FROM DIET COUNSELING TO SURGICAL PROCEDURES AND REHABILITATION. NEBRASKA MEDICINE - TNMC HAS GROWN INTO ONE OF THE BUSIEST CENTERS IN THE COUNTRY FOR VENTRICULAR ASSIST DEVICE OPERATIONS. THE CORPORATION HAS BEEN SUCCESSFUL IN RECRUITING PHYSICIANS AND HAS THE ONLY HEART FAILURE SPECIALIST IN THE REGION AND THE ONLY HEART FAILURE PROGRAM CERTIFIED BY THE JOINT COMMISSION IN THE STATE OF NEBRASKA. IN 2016, TNMC BEGAN A LUNG TRANSPLANT PROGRAM AND IN DECEMBER OF 2017 PERFORMED THE STATE'S FIRST EVER HEART AND LUNG TRANSPLANT. IN THE YEAR ENDED JUNE 30, 2018, TNMC PERFORMED 9 LUNG TRANSPLANTS. THE CONGESTIVE HEART FAILURE PROGRAM AND ACUTE MYOCARDIAL INFARCTION PROGRAM EACH RECEIVED THE GOLD SEAL OF APPROVAL CERTIFICATION FROM AMERICAN HEART ASSOCIATION AND ARE CERTIFIED BY THE JOINT COMMISSION. THESE SERVICES ARE THE FIRST AND ONLY NATIONALLY CERTIFIED PROGRAMS OF THEIR KIND IN THE STATE OF NEBRASKA. THE CHEST PAIN CENTER HAS RECEIVED FULL CHEST PAIN CENTER ACCREDITATION FROM THE SOCIETY OF CHEST PAIN CENTERS. THE NEBRASKA MEDICAL CENTER HAS BEEN RECOGNIZED FOR SERVICE EXCELLENCE UNDER THE J.D. POWER AND ASSOCIATES DISTINGUISHED HOSPITAL PROGRAM. WE HAVE THE ONLY JOINT COMMISSION CERTIFIED DESTINATION THERAPY PROGRAM IN THE STATE AND ARE THE ONLY HOSPITAL IN THE REGION PERFORMING ADULT HEART TRANSPLANTS AND IMPLANTING TOTAL ARTIFICIALS HEARTS. THE HOSPITAL TREATS PATIENTS FROM THE SURROUNDING REGION AND IN THE YEAR ENDED JUNE 30, 2018, APPROXIMATELY 812 OPEN HEART SURGERIES WERE PERFORMED, 43 HEART TRANSPLANTS, 41 MECHANICAL CIRCULATORY SYSTEM DEVICE IMPLANTATIONS.GeographiesNot indicatedDatesJul 1, 2017 – Jun 30, 2018Source990No causes providedNo populations provided–$143.9MProgram 3 [2018]
NEUROLOGY SCIENCES SERVICE LINE THE CORE SERVICES INCLUDE PRECISE DIAGNOSIS AND TREATMENT OF STROKE AND VASCULAR DISEASE, MOVEMENT AND MEMORY DISORDERS, MULTIPLE SCLEROSIS BRAIN AND SPINAL TUMORS, SPINE AS WELL AS EPILEPSY. THE EPILEPSY CENTER IS THE ONLY LEVEL 4 CENTER IN THE REGION AND TREATS PATIENTS FROM THE STATE OF NEBRASKA AND THE REGION. THE CORPORATION HAS ONE OF FEW MAGNETOENCEPHALOGRAPH (MEG) SCANNERS AND TRAINED MEG SCIENTISTS IN THE REGION. THE MEG CAN DETECT BRAIN ACTIVITY IN MUCH GREATER DETAIL AND WITH MORE ACCURACY THAN PREVIOUS METHODS AND ADVANCES PATIENT CARE AND RESEARCH OPPORTUNITIES GREATLY. THE CORPORATION HAS EARNED THE AMERICAN HEART ASSOCIATION/AMERICAN STROKE ASSOCIATION'S GET WITH THE GUIDELINES STROKE GOLD PLUS ACHIEVEMENT AWARD. GET WITH THE GUIDELINES IS A HOSPITAL-BASED, QUALITY-IMPROVEMENT PROGRAM DESIGNED TO ENSURE HOSPITALS CONSISTENTLY CARE FOR CARDIAC AND STROKE PATIENTS FOLLOWING THE MOST UP-TO-DATE GUIDELINES AND RECOMMENDATIONS. THE CORPORATION ALSO HOSTS THE ONLY YOUNG ADULT STROKE SUPPORT GROUP TO ADDRESS THE EMOTION AND PHYSICAL CHALLENGES OF RECOVERING FROM STROKE. DURING FISCAL YEAR 2018, NEUROSCIENCES INCURRED OVER 5,679 INPATIENTS WITH OVER 28,016 PATIENT DAYS AND OVER 141,031 OUTPATIENT BILLING UNITS APPROXIMATELY 55% OF THE REVENUE WAS DERIVED FROM INPATIENT CASES.GeographiesNot indicatedDatesJul 1, 2017 – Jun 30, 2018Source990No causes providedNo populations provided–$168.6M
Copyright 2026. All rights reserved to Chario Inc. (d.b.a. Impala)